Moisés Selman

63.5k total citations · 11 hit papers
341 papers, 26.1k citations indexed

About

Moisés Selman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Moisés Selman has authored 341 papers receiving a total of 26.1k indexed citations (citations by other indexed papers that have themselves been cited), including 277 papers in Pulmonary and Respiratory Medicine, 45 papers in Physiology and 43 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Moisés Selman's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (240 papers), Inhalation and Respiratory Drug Delivery (42 papers) and Pulmonary Hypertension Research and Treatments (42 papers). Moisés Selman is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (240 papers), Inhalation and Respiratory Drug Delivery (42 papers) and Pulmonary Hypertension Research and Treatments (42 papers). Moisés Selman collaborates with scholars based in Mexico, United States and United Kingdom. Moisés Selman's co-authors include Annie Pardo, Talmadge E. King, Miguel Gaxiola, Naftali Kaminski, Mayra Mejía, Carina Becerril, Remedios Ramı́rez, Carlos Ramos, Ganesh Raghu and Vı́ctor Ruiz and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Moisés Selman

333 papers receiving 25.5k citations

Hit Papers

Idiopathic pulmonary fibrosis 2001 2026 2009 2017 2011 2001 2017 2011 2012 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Idiopathic pulmonary fibrosis
    2011 1.6k citations Talmadge E. King, Annie Pardo et al. profile →
  2. Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
    2001 1.4k citations Moisés Selman, Talmadge E. King et al. profile →
  3. Idiopathic pulmonary fibrosis
    2017 903 citations Annie Pardo, Ganesh Raghu et al. profile →
  4. Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
    2011 811 citations Ulrich Costabel, Moisés Selman et al. profile →
  5. An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
    2012 720 citations Keith C. Meyer, Ganesh Raghu et al. American Journal of Respiratory and Critical Care Medicine profile →
  6. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
    2007 626 citations Andrew M. Tager, Moisés Selman et al. profile →
  7. Idiopathic Pulmonary Fibrosis
    2007 478 citations Moisés Selman, Mayra Mejía et al. profile →
  8. Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis
    2010 410 citations Kusum Pandit, David L. Corcoran et al. American Journal of Respiratory and Critical Care Medicine profile →
  9. Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
    2016 330 citations Vincent Cottin, Roland M. du Bois et al. profile →
  10. Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
    2017 312 citations Annie Pardo, Moisés Selman et al. profile →
  11. An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis
    2017 280 citations Gísli Jenkins, Oliver Eickelberg et al. American Journal of Respiratory Cell and Molecular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moisés Selman Mexico 81 19.4k 4.8k 4.3k 2.8k 2.4k 341 26.1k
Annie Pardo Mexico 70 14.0k 0.7× 4.2k 0.9× 2.7k 0.6× 1.7k 0.6× 1.5k 0.6× 193 18.7k
Paul W. Noble United States 83 16.2k 0.8× 6.9k 1.4× 5.5k 1.3× 1.4k 0.5× 3.1k 1.3× 208 30.1k
Gary W. Hunninghake United States 82 13.4k 0.7× 4.6k 1.0× 8.7k 2.0× 1.5k 0.6× 4.0k 1.6× 273 24.9k
Victor J. Thannickal United States 85 11.9k 0.6× 10.2k 2.2× 4.1k 1.0× 1.1k 0.4× 2.2k 0.9× 231 28.7k
Ganesh Raghu United States 81 22.0k 1.1× 2.2k 0.5× 7.6k 1.8× 1.9k 0.7× 3.6k 1.5× 332 26.7k
Sem H. Phan United States 76 8.4k 0.4× 5.6k 1.2× 2.1k 0.5× 864 0.3× 1.4k 0.6× 208 20.0k
Talmadge E. King United States 84 26.7k 1.4× 2.0k 0.4× 8.9k 2.1× 2.8k 1.0× 3.8k 1.6× 232 30.6k
Rubin M. Tuder United States 98 20.6k 1.1× 9.7k 2.0× 5.0k 1.2× 533 0.2× 3.2k 1.3× 330 33.1k
Bethany B. Moore United States 71 7.8k 0.4× 4.8k 1.0× 1.8k 0.4× 882 0.3× 2.1k 0.8× 259 17.5k
Robert Homer United States 72 7.9k 0.4× 5.6k 1.2× 5.7k 1.3× 776 0.3× 1.7k 0.7× 203 21.2k

Countries citing papers authored by Moisés Selman

Since Specialization
Citations

This map shows the geographic impact of Moisés Selman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moisés Selman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moisés Selman more than expected).

Fields of papers citing papers by Moisés Selman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moisés Selman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moisés Selman. The network helps show where Moisés Selman may publish in the future.

Co-authorship network of co-authors of Moisés Selman

This figure shows the co-authorship network connecting the top 25 collaborators of Moisés Selman. A scholar is included among the top collaborators of Moisés Selman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moisés Selman. Moisés Selman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramón‐Luing, Lucero A., Laura E. Martínez-Gómez, Carlos Martínez-Armenta, et al.. (2025). TNF/IFN-γ Co-Signaling Induces Differential Cellular Activation in COVID-19 Patients: Implications for Patient Outcomes. International Journal of Molecular Sciences. 26(3). 1139–1139.
2.
Buendía-Roldán, Ivette, Lucero A. Ramón‐Luing, Ramcés Falfán‐Valencia, et al.. (2025). Altered immune surveillance of B and T cells in patients with persistent residual lung abnormalities 12 months after severe COVID-19. Respiratory Research. 26(1). 22–22.
3.
Maher, Toby M., Gísli Jenkins, Vincent Cottin, et al.. (2024). Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial. ERJ Open Research. 10(4). 335–2023. 3 indexed citations
4.
Chávez‐Galán, Leslie, Ivette Buendía-Roldán, Ranferi Ocaña‐Guzmán, et al.. (2020). Decreased expression of transmembrane TNFR2 in lung leukocytes subpopulations of patients with non-fibrotic hypersensitivity pneumonitis compared with the fibrotic disease. Clinical Immunology. 215. 108424–108424. 4 indexed citations
5.
Machahua, Carlos, Ivette Buendía-Roldán, Ranferi Ocaña‐Guzmán, et al.. (2020). CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile. Thorax. 76(2). 152–160. 11 indexed citations
6.
Ahluwalia, Neil, Paula Grasberger, Carol Feghali‐Bostwick, et al.. (2015). Fibrogenic Lung Injury Induces Non–Cell-Autonomous Fibroblast Invasion. American Journal of Respiratory Cell and Molecular Biology. 54(6). 831–842. 23 indexed citations
7.
Thannickal, Victor J., M.R. Ven Murthy, William E. Balch, et al.. (2015). Blue Journal Conference. Aging and Susceptibility to Lung Disease. American Journal of Respiratory and Critical Care Medicine. 191(3). 261–269. 124 indexed citations
8.
Selman, Moisés & Annie Pardo. (2014). Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis. An Integral Model. American Journal of Respiratory and Critical Care Medicine. 189(10). 1161–1172. 344 indexed citations
9.
Meyer, Keith C., Ganesh Raghu, Robert P. Baughman, et al.. (2012). An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 185(9). 1004–1014. 720 indexed citations breakdown →
10.
Selman, Moisés, Annie Pardo, & Talmadge E. King. (2012). Hypersensitivity Pneumonitis: Insights in Diagnosis and Pathobiology. American Journal of Respiratory and Critical Care Medicine. 186(4). 314–324. 300 indexed citations
11.
Yu, Guoying, Anil V. Parwani, Daniel J. Kass, et al.. (2012). Matrix Metalloproteinase-19 Is a Key Regulator of Lung Fibrosis in Mice and Humans. American Journal of Respiratory and Critical Care Medicine. 186(8). 752–762. 82 indexed citations
12.
Selman, Moisés, Y. Lacasse, Annie Pardo, & Yvon Cormier. (2010). Hypersensitivity Pneumonitis Caused by Fungi. Proceedings of the American Thoracic Society. 7(3). 229–236. 59 indexed citations
13.
Eickelberg, Oliver & Moisés Selman. (2010). Update in Diffuse Parenchymal Lung Disease 2009. American Journal of Respiratory and Critical Care Medicine. 181(9). 883–888. 14 indexed citations
14.
Alba, Carolina García de, Carina Becerril, Vı́ctor Ruiz, et al.. (2010). Expression of Matrix Metalloproteases by Fibrocytes: Possible Role in Migration and Homing. American Journal of Respiratory and Critical Care Medicine. 182(9). 1144–1152. 94 indexed citations
15.
Pandit, Kusum, David L. Corcoran, Hanadie Yousef, et al.. (2010). Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 182(2). 220–229. 410 indexed citations breakdown →
16.
Barrera, Lourdes, Felipe Mendoza, Joaquı́n Zúñiga, et al.. (2007). Functional Diversity of T-Cell Subpopulations in Subacute and Chronic Hypersensitivity Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 177(1). 44–55. 127 indexed citations
17.
Camarena, Ángel, Mayra Mejía, Andrea Estrada, et al.. (2001). Major Histocompatibility Complex and Tumor Necrosis Factor- α Polymorphisms in Pigeon Breeder's Disease. American Journal of Respiratory and Critical Care Medicine. 163(7). 1528–1533. 103 indexed citations
18.
Ortiz, Luis A., Joseph A. Lasky, Evelyne Gozal, et al.. (2001). Tumor Necrosis Factor Receptor Deficiency Alters Matrix Metalloproteinase 13/Tissue Inhibitor of Metalloproteinase 1 Expression in Murine Silicosis. American Journal of Respiratory and Critical Care Medicine. 163(1). 244–252. 46 indexed citations
19.
Pardo, Annie, Roberto Barrios, Miguel Gaxiola, et al.. (2000). Increase of Lung Neutrophils in Hypersensitivity Pneumonitis Is Associated with Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 161(5). 1698–1704. 118 indexed citations
20.
Pérez‐Ramos, Julia, et al.. (1999). Matrix Metalloproteinases 2, 9, and 13, and Tissue Inhibitors of Metalloproteinases 1 and 2 in Experimental Lung Silicosis. American Journal of Respiratory and Critical Care Medicine. 160(4). 1274–1282. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annie Pardo Breakdown of academic impact, for papers by Paul W. Noble Breakdown of academic impact, for papers by Gary W. Hunninghake Breakdown of academic impact, for papers by Victor J. Thannickal Breakdown of academic impact, for papers by Ganesh Raghu Breakdown of academic impact, for papers by Sem H. Phan Breakdown of academic impact, for papers by Talmadge E. King Breakdown of academic impact, for papers by Rubin M. Tuder Breakdown of academic impact, for papers by Bethany B. Moore Breakdown of academic impact, for papers by Robert Homer
Rankless by CCL
2026